Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Arrhythmia; This is a spontaneous report from a contactable physician via the Agency (LRB), downloaded from the Agency Regulatory Agency-WEB (NL-LRB-00454760). A 70-year-old male patient received the first dose of BNT162B2 (COMIRNATY; Lot number EM0477) via an unspecified route of administration on 04Feb2021 at single dose for COVID-19 immunisation. Relevant medical history included ongoing implantable defibrillator insertion and ongoing arrhythmia. Concomitant medications included furosemide 40 mg, metoprolol 100 mg, periciazine (NEULEPTIL) 5 mg, perindopril erbumine 2 mg, amiodarone (AMIODARON) 200 mg, acenocoumarol 1 mg, rosuvastatin [ROSUVASTATINE] 10 mg and metformin hydrochloride (GLUCIENT SR) 500 mg. On 06Feb2021, the patient experienced arrhythmia for which he was hospitalized on the same day. The reporter specified that the patient had previous hospitalization''s due to this arrhythmia. After a hospitalization of 2 weeks, the patient deceased on an unspecified date in 2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Based on his known heart rhythm problem
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166